在那些多次接种了COVID-19疫苗的人群中,COVID-19诱导的异性下呼吸道炎症
Yosuke Fukuda1,2, Hidenori Hayashi3, Hironori Sagara2
1Department of Medicine, Division of Respiratory Medicine and Allergology, Yamanashi Red Cross Hospital, Yamanashi, JPN.
Cureus
|June 2, 2023
概括
一名患者在COVID-19感染后,即使在接种疫苗后,也出现了eosinophilic下呼吸道炎症. 及时的皮质类固醇治疗改善了她的症状,突出显示了COVID-19和这种炎症状况之间的潜在联系.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 可以导致各种呼吸道并发症.
- 埃索诺菲尔下呼吸道炎症是一种独特的肺部疾病.
- 需要进一步了解COVID-19和eosinophilic炎症之间的关系,特别是在接种疫苗后.
研究的目的:
- 报告一个患有COVID-19病史的患者患有eosinophilic下呼吸道炎症的情况.
- 突出诊断发现和成功治疗这种情况.
- 为了强调COVID-19和eosinophilic下呼吸道炎症之间的潜在关联,即使在接种疫苗的个体中.
主要方法:
- 一个29岁的女性患者的病例报告.
- 诊断评估包括胸部计算机断层扫描 (CT),对外围乙友爱症的评估和分数呼出的氧化 (FeNO) 测量.
- 治疗包括全身性皮质类固醇.
主要成果:
- 胸部CT显示了双边上叶片的地面玻璃不透明.
- 该患者呈现出埃索诺菲利亚和升高的FeNO水平,导致诊断为埃索诺菲尔下呼吸道炎症.
- 系统性皮质类固醇治疗导致症状改善和放射学解决.
结论:
- COVID-19可能与酸性下呼吸道炎症的发展有关.
- 这种关联甚至可以发生在接受多剂COVID-19疫苗的患者中.
- 临床医生应将COVID-19视为氨酸性下呼吸道炎症的潜在触发因素,并考虑及时接受皮质类固醇治疗.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
COPD: Pathogenesis and Clinical Features
371
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
371
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
361
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
361
Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Vaccinations
44.9K
Overview
44.9K


